If possible, this last week was even crazier than the week before. Bills are being gutted and amended at an amazing rate. Two such bills that are causing significant concern for pharmacy are SB 1390 (Corbett) and SB 2779 (Solorio).  SB 1390 is an attempt by angry consumer groups and the author to overturn recent regulations developed by the Board of Pharmacy to address a new, safer patient centered prescription label. CPhA Past President George Pennebaker had the following to say, "Senator Corbett has hijacked her own bill and created requirements that cannot be met.  Most pharmacists are fluent in one language, many are fluent in two. None are fluent in 100 languages. There are no translation services that will guarantee that their translations are correct. The Board of Pharmacy has done the work needed to properly deal with the issues being addressed. They have done their homework, listened and made decisions that are good for the patients and capable of being followed. Senator Corbett needs to do the same thing before promoting such a drastic and impossible law."
 
SB 1390 goes too far, imposes a significant cost burden and requires translated label and materials, which currently do not exist and where they do exist, they do not guarantee to be accurate. The bill, if passed, would put pharmacists in an impossible situation of handing out materials that they cannot read and cannot verify as accurate. This will create a very unsafe situation. We ask for your help in opposing this bill.
 
SB 2779 was put forth this week to try to stop abuses regarding compounded prescriptions in the Workers' Compensation system. While CPhA supports reducing fraud, waste and abuse in any setting, we solidly OPPOSE this bill for going way too far in attempting to unreasonably regulate compounding. We are working with the sponsors and the author and other interested stakeholders to come up with a better solution for the problem. CPhA's position is opposed unless amended.